Related Experiment Video
Updated: Oct 8, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
[Clozapine-induced toxic hepatitis]
J T Larsen1, S V Clemensen, N A Klitgaard
1Odense Universitetshospital, afdeling KKA, sektion for klinisk farmakologi og psykiatrisk afdeling P.
Abstract:
A case of clozapine-induced toxic hepatitis in a 49-year old woman with schizophrenia is described. The daily clozapine dose was clinically titrated to 300 mg. Subsequently, the patient experienced lethargy and anorexia, and fever, eosinophilia, leucocytosis and abnormal liver parameters were found. The serum concentration of clozapine was 8595 nmol/l, and treatment was discontinued. After eight days, the condition stabilised, and low-dose clozapine treatment was successfully reinstituted with serum monitoring (TDM).
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Psychosis: Goals of Pharmacotherapy
Drug Toxicity: Risk factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Allergic Reactions

